🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11283+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11283 recruiting trials

Phase 3RecruitingNCT06964568

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

🏥 Fudan University📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06764082

Nutritional Intervention for Biliary Atresia

🏥 Tongji Hospital📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT07010237

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

👨‍⚕️ Jun Shi, PhD, Institute of Hematology & Blood Diseases Hospital, CAMS📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06612541

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

🏥 Vanderbilt University Medical Center📍 1 site📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06841042

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

🏥 Sinocelltech Ltd.📍 14 sites📅 Started Feb 2025View details ↗
RecruitingNCT06801821

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

👨‍⚕️ Giacomo Caldarola, MD, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT07033260

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

🏥 First Affiliated Hospital of Wannan Medical College📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06797284

The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders

🏥 Second Affiliated Hospital of Soochow University📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06760507

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

👨‍⚕️ Yue Guan, Emory University Hospital/Winship Cancer Institute📍 1 site📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06679881

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

👨‍⚕️ Study Director, Pharvaris, Pharvaris Netherlands B.V.📍 24 sites📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT05946772

Cyclosporine In Takotsubo Syndrome

👨‍⚕️ Norbert Frey, MD, University Hospital Heidelberg📍 21 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06851338

Pediatric Down Syndrome Post-Approval Study

🏥 Inspire Medical Systems, Inc.📍 6 sites📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT05439278

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

👨‍⚕️ Chan Woo Wee, MD, PhD, Severance Hospital📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06970236

Resistance Exercise in Patients With Ocular Melanoma

🏥 University of Valencia📍 1 site📅 Started Feb 2025View details ↗
NAEnrolling by InvitationNCT06697327

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

👨‍⚕️ ZhangBiao Long, Doctor, Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06798844

Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease

👨‍⚕️ Philippe De Vloo, MD, PhD, Prof., Department of Neurosurgery, University Hospitals Leuven📍 1 site📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06803875

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

👨‍⚕️ Susanne Baumeister, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Jan 2025View details ↗
Phase 4RecruitingNCT06832514

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

👨‍⚕️ Prof. Dr. Isabel Leroux-Roels, PhD, MD, CEVAC, University Hospital Ghent, Belgium📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06514794

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

👨‍⚕️ Cherry Thomas, MD, Wugen, Inc.📍 10 sites📅 Started Jan 2025View details ↗
EARLY_Phase 1RecruitingNCT06793241

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

👨‍⚕️ He Huang, MD, Zhejiang University📍 1 site📅 Started Jan 2025View details ↗
← PreviousPage 169 of 565Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →